The trademark epiPS was filed by Fondation Cardiométabolisme et Nutrition - ICAN, a corporation established under the laws of the French Republic (the "Applicant"). The application was published for oppositions on August 21, 2022, and received one opposition filed on November 7, 2022 by Henkel AG & Co. KGaA on Likelihood of confusion. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued November 7, 2022
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
Goods And Services
The mark was filed in class 1 with following description of goods:
Reagents for research and laboratory use to reprogram induced stem cells
Tissue culture medium for research and laboratory use to reprogram induced stem cells
Chemicals for use in science to reprogram induced stem cells
Biological preparations and biological tissues for scientific (non-medical) use to reprogram induced stem cells
Tissue culture medium and reagents for research and laboratory use to reprogram induced stem cells
Cell culture medium for growing stem cells to reprogram induced stem cells.
The mark was filed in class 5 with Biological preparations, namely, cell culture medium for reprograming induced growing stem cells and Biological preparations and biological tissues for medical use to reprogram induced stem cells..
The mark was filed in class 42 with Service and Support in cellular bio-engineering and feasability study to reprogram induced stem cells.